Custom Search
News
Friday 02 February 2007
Aurobindo Pharma gets US FDA nod for Cefprozil
Drug maker Aurobindo Pharma Ltd. said on Friday it received the U.S. Food and Drug Administration approval for Cefprozil oral suspension variants.
Cefprozil, a generic version of Bristol-Myers Squibb's Cefzil, is an antibiotic used to treat to lower respiratrory tract infection and skin and soft tissue infections, Aurobindo said in a statement.